1. Loehr WJ, Mujahed Z, Zahn FD, Gray GF, Thorbjarnarson B. Primary lymphoma of the gastrointestinal tract: a review of 100 cases. Ann Surg. 1969. 170:232–238.
2. Kim DH, Sohn SK, Jung JT, et al. Mantle cell lymphoma presented as multiple lymphomatous polyposis: clinical review of 4 cases. Korean J Med. 2000. 59:413–422.
3. Lim HJ, Choi P, Hur JW, et al. A case of mantle cell lymphoma presenting as multiple lymphomatous polyposis involving skeletal muscles. Korean J Gastrointest Endosc. 2003. 27:15–20.
4. Hemminki K, Lenner P, Sundquist J, Bermejo JL. Risk of subsequent solid tumors after non-Hodgkin's lymphoma: effect of diagnostic age and time since diagnosis. J Clin Oncol. 2008. 26:1850–1857.
5. Barista I, Cabanillas F, Romaguera JE, et al. Is there an increased rate of additional malignancies in patients with mantle cell lymphoma? Ann Oncol. 2002. 13:318–322.
6. Lolli E, Matteoni R, Barbieri A, D'Ambrosi M, Archontakis F. Non-Hodgkin's lymphoma, renal carcinoma, and meningioma. A clinical case. Ann Ital Chir. 1998. 69:101–104.
7. Dreyling M, Hiddemann W. European MCL Network. Current treatment standards and emerging strategies in mantle cell lymphoma. Hematology Am Soc Hematol Educ Program. 2009. 542–551.
8. Isaacson PG, MacLennan KA, Subbuswamy SG. Multiple lymphomatous polyposis of the gastrointestinal tract. Histopathology. 1984. 8:641–656.
9. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994. 84:1361–1392.
10. Tagle P, Villanueva P, Torrealba G, Huete I. Intracranial metastasis or meningioma? An uncommon clinical diagnostic dilemma. Surg Neurol. 2002. 58:241–245.
11. Norton AJ, Matthews J, Pappa V, et al. Mantle cell lymphoma: natural history defined in a serially biopsied population over a 20-year period. Ann Oncol. 1995. 6:249–256.
12. Ruskoné-Fourmestraux A, Delmer A, Lavergne A, et al. Groupe D'étude des Lymphomes Digestifs. Multiple lymphomatous polyposis of the gastrointestinal tract: prospective clinicopathologic study of 31 cases. Gastroenterology. 1997. 112:7–16.
13. Zucca E, Stein H, Coiffier B. European Lymphoma Task Force (ELTF): Report of the workshop on mantle cell lymphoma (MCL). Ann Oncol. 1994. 5:507–511.
14. Swerdlow SH, Williams ME. From centrocytic to mantle cell lymphoma: a clinicopathologic and molecular review of 3 decades. Hum Pathol. 2002. 33:7–20.
15. Hoster E, Dreyling M, Klapper W, et al. German Low Grade Lymphoma Study Group (GLSG). European Mantle Cell Lymphoma Network. A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma. Blood. 2008. 111:558–565.
16. Leonard JP, Schattner EJ, Coleman M. Biology and management of mantle cell lymphoma. Curr Opin Oncol. 2001. 13:342–347.
17. Herrmann A, Hoster E, Zwingers T, et al. Improvement of overall survival in advanced stage mantle cell lymphoma. J Clin Oncol. 2009. 27:511–518.